The fibrinolytic receptor for urokinase activates the G protein-coupled chemotactic receptor FPRL1/LXA4R.
about
The prognostic value of the suPARnostic ELISA in HIV-1 infected individuals is not affected by uPAR promoter polymorphismsStructural analysis and tissue localization of human C4.4A: a protein homologue of the urokinase receptorUrokinase-induced signaling in human vascular smooth muscle cells is mediated by PDGFR-betaRNA interference-directed knockdown of urokinase plasminogen activator and urokinase plasminogen activator receptor inhibits prostate cancer cell invasion, survival, and tumorigenicity in vivouPAR promotes formation of the p130Cas-Crk complex to activate Rac through DOCK180.International Union of Basic and Clinical Pharmacology. LXXIII. Nomenclature for the formyl peptide receptor (FPR) familyUrokinase receptor and resistance to targeted anticancer agentsRecognition of bacterial signal peptides by mammalian formyl peptide receptors: a new mechanism for sensing pathogens.Single amino acid substitutions in the chemotactic sequence of urokinase receptor modulate cell migration and invasionThe urokinase receptor (uPAR) and the uPAR-associated protein (uPARAP/Endo180): membrane proteins engaged in matrix turnover during tissue remodelingSoluble urokinase-type plasminogen activator receptor inhibits cancer cell growth and invasion by direct urokinase-independent effects on cell signaling.uPAR induces epithelial-mesenchymal transition in hypoxic breast cancer cells.uPAR-induced cell adhesion and migration: vitronectin provides the keyThe Concise Guide to PHARMACOLOGY 2013/14: G protein-coupled receptorsMembrane-anchored uPAR regulates the proliferation, marrow pool size, engraftment, and mobilization of mouse hematopoietic stem/progenitor cells.Modulation of cellular migration and survival by c-Myc through the downregulation of urokinase (uPA) and uPA receptorThe G-protein-coupled formylpeptide receptor FPR confers a more invasive phenotype on human glioblastoma cells.Dependence on endocytic receptor binding via a minimal binding motif underlies the differential prognostic profiles of SerpinE1 and SerpinB2 in cancer.Binding of urokinase plasminogen activator to gp130 via a putative urokinase-binding consensus sequence.Elevated urinary levels of urokinase-type plasminogen activator receptor (uPAR) in pancreatic ductal adenocarcinoma identify a clinically high-risk group.The Kruppel-like KLF4 transcription factor, a novel regulator of urokinase receptor expression, drives synthesis of this binding site in colonic crypt luminal surface epithelial cells.Mapping of the vitronectin-binding site on the urokinase receptor: involvement of a coherent receptor interface consisting of residues from both domain I and the flanking interdomain linker region.Effects of Acute Exercise on Circulating Soluble Form of the Urokinase Receptor in Patients With Major Depressive Disorder.Formyl peptide receptors promotes neural differentiation in mouse neural stem cells by ROS generation and regulation of PI3K-AKT signalingRetro-inverso Urokinase Receptor Antagonists for the Treatment of Metastatic Sarcomas.Cleavage of the urokinase receptor (uPAR) on oral cancer cells: regulation by transforming growth factor - β1 (TGF-β1) and potential effects on migration and invasion.Human ribonuclease A superfamily members, eosinophil-derived neurotoxin and pancreatic ribonuclease, induce dendritic cell maturation and activationThe urokinase receptor supports tumorigenesis of human malignant pleural mesothelioma cells.Urokinase-urokinase receptor interaction mediates an inhibitory signal for HIV-1 replicationTumour microenvironments induce expression of urokinase plasminogen activator receptor (uPAR) and concomitant activation of gelatinolytic enzymes.Anti-inflammatory role of the murine formyl-peptide receptor 2: ligand-specific effects on leukocyte responses and experimental inflammation.Urokinase receptor promotes ovarian cancer cell dissemination through its 84-95 sequence.The plasminogen activation system modulates differently adipogenesis and myogenesis of embryonic stem cells.Involvement of the soluble urokinase receptor in chondrosarcoma cell mobilization.Coordinate regulation of fibronectin matrix assembly by the plasminogen activator system and vitronectin in human osteosarcoma cells.Distinct signaling cascades elicited by different formyl peptide receptor 2 (FPR2) agonistsTherapeutic effects of s-petasin on disease models of asthma and peritonitis.A deficiency of uPAR alters endothelial angiogenic function and cell morphology.Urokinase and its receptors in chronic kidney disease.Molecular mechanisms of glioma invasiveness: the role of proteases.
P2860
Q21261761-D1817FD2-8DB1-49E6-BB7B-BC8DDE1E0972Q24315974-5B1B1F43-E2B2-4BF6-9CE4-C6B31C223827Q24529131-E229CEB4-5FAD-440E-93B4-E41D39CA8ADAQ24539093-7FB13D8E-9A43-437D-921A-29E67AA82C28Q24642555-AC8A9061-56DE-4774-A9E9-DDBEC8169D75Q24652940-DDFA5D76-9548-4C72-AC9C-33270DB1E0AEQ26797385-6396FA98-366D-4052-A6CE-40CAF08CE6A4Q27313685-CF89C1DE-61F9-42D9-BA2D-0BE24B1EAC62Q27319474-472B11E4-BE43-4B94-B4E1-1248BA87819FQ28257803-DDABC65F-C9D1-4C9B-B80C-A62ADB9488FAQ30311208-866D357D-C7AE-4251-B574-AC76053B4B38Q30443804-25F90BA2-7CC1-4210-9604-D0FF197F8D8AQ30444144-7014F8DE-C6DA-4164-A0E5-828D2C87B486Q30486707-743F151B-2156-4FFE-86DC-6CBE21BEF0E3Q30486721-A8FD3C79-2D15-4D96-9D02-2D46D3801D0EQ30493647-513D48DC-CC47-465F-9A1F-05B5FE603AD7Q30493852-B367C4D2-16A6-4E81-947B-B372FFE82520Q30502082-75D1158F-D208-422F-888E-27C3A62EF848Q30911713-EF4A5AD7-03A0-490B-A0CA-3123BAA3341AQ31038443-A45A05B4-0414-4963-B58B-76FFC2564E10Q33199829-D5AFA012-1BF0-4774-8817-DD24523330D8Q33278178-5F6DF548-01E2-4A0F-9795-BA38EA506691Q33580655-033745E4-EFC4-424F-82B1-F2000505BFF5Q33670941-7071800E-73C4-4062-B609-A3C520B7295CQ33683537-889BBE54-68F4-417A-BD2B-85718DFB91EBQ33709060-7F9E77DE-969C-4871-A0CE-F98E08FF78CBQ33761299-65DFE7CD-BB85-4265-94D6-0B284999E3A8Q33938369-8AA907F2-8544-4FE8-99B2-C11ED42DA2A7Q34066122-3FB7407A-3AB5-4D06-867B-17DF7D4DE673Q34089936-056466EF-A64F-4544-9D42-6CE175BA7E28Q34095174-4ECE1A81-B243-4A70-96CE-C9C7C39C333CQ34100895-D02A967F-4865-4AFE-8325-1A56EB23FCDBQ34473975-3D6E1C20-2B46-42B9-8B45-A699A6D95CCAQ34495535-7A420B98-26FA-4BB6-9F1C-753616AD9DAAQ34567465-0FA18DF9-0531-4D33-8FD0-45F8B54EE66AQ34645842-ED791BDE-EC7F-4D67-AAB1-125F5A173197Q34865112-B76A755D-7B58-4286-B004-35CF7DE3D351Q35019176-768DF33D-9A7A-465D-A6B4-3EFA8A9B8D13Q35124141-242BBB79-B718-4AC5-87CC-76EB8EAB5B9CQ35166808-D3340947-DB3B-4088-893E-0C2CB19BC212
P2860
The fibrinolytic receptor for urokinase activates the G protein-coupled chemotactic receptor FPRL1/LXA4R.
description
2002 nî lūn-bûn
@nan
2002 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
The fibrinolytic receptor for ...... motactic receptor FPRL1/LXA4R.
@ast
The fibrinolytic receptor for ...... motactic receptor FPRL1/LXA4R.
@en
The fibrinolytic receptor for ...... motactic receptor FPRL1/LXA4R.
@nl
type
label
The fibrinolytic receptor for ...... motactic receptor FPRL1/LXA4R.
@ast
The fibrinolytic receptor for ...... motactic receptor FPRL1/LXA4R.
@en
The fibrinolytic receptor for ...... motactic receptor FPRL1/LXA4R.
@nl
prefLabel
The fibrinolytic receptor for ...... motactic receptor FPRL1/LXA4R.
@ast
The fibrinolytic receptor for ...... motactic receptor FPRL1/LXA4R.
@en
The fibrinolytic receptor for ...... motactic receptor FPRL1/LXA4R.
@nl
P2093
P2860
P356
P1476
The fibrinolytic receptor for ...... emotactic receptor FPRL1/LXA4R
@en
P2093
P2860
P304
P356
10.1073/PNAS.022652999
P407
P50
P577
2002-01-29T00:00:00Z